NOV anticorps (C-Term)
Aperçu rapide pour NOV anticorps (C-Term) (ABIN630288)
Antigène
Voir toutes NOV AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- NOV antibody was raised against the C terminal of NOV
-
Purification
- Purified
-
Immunogène
- NOV antibody was raised using the C terminal of NOV corresponding to a region with amino acids KTIQAEFQCSPGQIVKKPVMVIGTCTCHTNCPKNNEAFLQELELKTTRGK
-
-
-
-
Indications d'application
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
NOV Blocking Peptide, (ABIN940066), is also available for use as a blocking control in assays to test for specificity of this NOV antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NOV antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NOV (Nephroblastoma Overexpressed (NOV))
-
Autre désignation
- NOV
-
Sujet
- As an immediate-early protein, NOV is likely to play a role in cell growth regulation.
-
Poids moléculaire
- 39 kDa (MW of target protein)
-
Pathways
- Smooth Muscle Cell Migration, Growth Factor Binding
Antigène
-